1. Sharma Sangeeta

9789352709892

10.5005/jp/books/18284_20

2/e

2020

9

1. Institute of Human Behavior and Allied Sciences, New Delhi, India, LRS Institute of Tuberculosis and Respiratory Diseases, New Delhi, LRS Institute of TB and Respiratory Diseases, New Delhi, India, LRS Institute of TB and RD, New Delhi, India, LRS Institute of TB and RD, New Delhi, LRS Institute of TB and Respiratory Diseases, New Delhi, Lala Ram Sarup Institute Tuberculosis and Respiratory Diseases, New Delhi, India, LRS Institute Tuberculosis and Respiratory Diseases, New Delhi, India, National institute TB and Respiratory Diseases; National Technical Working Group on Pediatric TB, MoHFW, GoI, New Delhi, India, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India; National Technical Working Group on Pediatric Tuberculosis, Ministry of Health & Family Welfare, Govt. of India, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India, Institute of Human Behavior and Allied Sciences (IHBAS), Shahdara, Delhi, India, Lala Ram Sarup Institute of Tuberculosis and Respir

Tuberculosis, bacillus Calmette-Guérin, BCG, epidemiology, vaccine, pulmonary TB, extrapulmonary TB, latent TB infection, vaccine development, oral vaccine, contraindication, BCG vaccination strategy